| Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
|---|
| 02/01/2001 | WO2001007433A2 Quinoline derivatives and their use as antibacterial agents |
| 02/01/2001 | WO2001007432A2 Aminopiperidine derivatives as antibacterials |
| 02/01/2001 | WO2001007419A1 Novel thiazine or pyrazine derivatives |
| 02/01/2001 | WO2001007412A1 Antiviral tetrahydroisichinolinsulfonamides |
| 02/01/2001 | WO2001007411A1 Biarylurea derivatives |
| 02/01/2001 | WO2001007409A1 Carbazole derivatives and their use as neuropeptide y5 receptor ligands |
| 02/01/2001 | WO2001007408A2 Novel method for preparing benzoperhydroisoindole compounds |
| 02/01/2001 | WO2001007406A1 Novel amide derivatives |
| 02/01/2001 | WO2001007050A1 Nociceptin receptor orl-1 agonists for use in treating cough |
| 02/01/2001 | WO2001007048A1 Small molecules useful in the treatment of inflammatory disease |
| 02/01/2001 | WO2001007022A2 Azetidine compounds in cns and eye diseases |
| 02/01/2001 | WO2000058405A3 Squaraine dyes |
| 02/01/2001 | WO2000038717A3 Use of a matrix metalloproteinase inhibitor and radiation as a combined treatment of neoplasia |
| 02/01/2001 | WO2000037107A3 Use of cyclooxygenase-2 inhibitor, a matrix metallaproteinase inhibitor, an antineoplastic agent and optionally radiation as a combination treatment of neoplasia |
| 02/01/2001 | WO2000003743A3 Use of inhibitors of prenyltransferases for inhibiting fungal growth |
| 02/01/2001 | DE4030603C2 New pyridyl pyrimidine cpds. for liq. crystal mediums - has chiral tilted smectic phase with wide ferroelectric phase range and favourable viscosity |
| 02/01/2001 | CA2382755A1 Substituted oxoazaheterocyclyl compounds |
| 02/01/2001 | CA2380389A1 Biarylurea derivatives |
| 02/01/2001 | CA2380218A1 Novel thiazine or pyrazine derivatives |
| 02/01/2001 | CA2379859A1 Novel method for preparing benzoperhydroisoindole compounds |
| 02/01/2001 | CA2379398A1 Nociceptin receptor orl-1 agonists for use in treating cough |
| 01/31/2001 | EP1072601A2 4-arylpiperidine derivatives for the treatment of pruritus |
| 01/31/2001 | EP1072597A1 Pyrazoles and their use as endothelin antagonists |
| 01/31/2001 | EP1072595A2 4-arylpiperidine derivatives for the treatment of pruritus |
| 01/31/2001 | EP1072588A1 Process for producing arylsulfenyl halide |
| 01/31/2001 | EP1072587A1 Sulfonamide derivatives and drugs containing the same as the active ingredient |
| 01/31/2001 | EP1072263A1 Amide derivatives and nociceptin antagonists |
| 01/31/2001 | EP1071701A1 Non-endogenous, constitutively activated human serotonin receptors and small molecule modulators thereof |
| 01/31/2001 | EP1071683A1 New compounds |
| 01/31/2001 | EP1071679A1 Novel heterocyclic compounds |
| 01/31/2001 | EP1071678A1 Chemical process for the production of sulphinyl derivatives by oxidation of the corresponding co-derivatives with perborates |
| 01/31/2001 | EP1071671A2 Triazolones with a neuroprotective action |
| 01/31/2001 | EP1071669A1 Bicyclic compounds having an anti-thrombitic effect |
| 01/31/2001 | EP1071668A1 5-aminoindeno(1,2-c)pyrazol-4-ones as anti-cancer and anti-proliferative agents |
| 01/31/2001 | EP1071666A1 Azacycloalkane derivatives, preparation and therapeutic application |
| 01/31/2001 | EP1071665A1 Substituted indolinones having an inhibiting effect on kinases and cycline/cdk complexes |
| 01/31/2001 | EP1071420A1 Indolyl-3-glyoxylic acid derivatives with antitumoral activity |
| 01/31/2001 | CN1282330A Substituted 2-(2,6-dioxo-3-fluoropiperidin-3-yl)-isoindolines and their use to reduce TNF & alpha levels |
| 01/31/2001 | CN1282329A I (ortho)-anthranilamide derivatives as anti-coagulants |
| 01/31/2001 | CN1282245A Molecular dispersion composition with enhanced bioavailability |
| 01/31/2001 | CN1281852A 三唑及咪唑衍生物 Triazole and imidazole derivatives |
| 01/31/2001 | CN1061346C Diazabicycloalkene derivatives and use, and drug composition containing said derivatives |
| 01/31/2001 | CN1061345C Process for preparation of polyaminotriazines |
| 01/30/2001 | US6180786 Antagonist for excitory amino acids |
| 01/30/2001 | US6180653 Aminopyrazole derivatives |
| 01/30/2001 | US6180652 Sulfoxide compounds and acetone complexes, and a process for producing the same |
| 01/30/2001 | US6180649 1-(4-piperidyl)-benzimidazoles having neurotrophic activity |
| 01/30/2001 | US6180647 Gastrointestinal disorders; nervous system disorders |
| 01/30/2001 | US6180646 Retroviral protease inhibitors |
| 01/30/2001 | US6180643 Antagonist of interleukins, tumor necrosis factor |
| 01/30/2001 | US6180640 Di- and tetra-hydroquinoline-indole antimicrobial agents, uses and compositions related thereto |
| 01/30/2001 | US6180629 [4,5]-Fused-1,3-disubstituted-1,2-diazine-6-one derivatives with nitrogen containing substitutents in position one for the treatment of neoplasia |
| 01/30/2001 | US6180628 Compounds, compositions and methods for treating influenza |
| 01/30/2001 | US6180627 Antithrombotic agents |
| 01/30/2001 | US6180623 Used as analgesics and anti-pruritic agents |
| 01/30/2001 | CA2191352C Quinoline derivatives as tachykinin nk3 receptor antagonists |
| 01/25/2001 | WO2001005784A1 NITROGEN CONTAINING HETEROBICYCLES AS FACTOR Xa INHIBITORS |
| 01/25/2001 | WO2001005783A1 Bradykinin b1 receptor antagonists |
| 01/25/2001 | WO2001005782A1 Novel diphenyl-piperidine derivate |
| 01/25/2001 | WO2001005774A1 Heteroaromatic ring compounds |
| 01/25/2001 | WO2001005773A1 Conjugates of sodium channel blockers and methods of using the same |
| 01/25/2001 | WO2001005772A1 Pyrazinones, compositions containing such compounds |
| 01/25/2001 | WO2001005771A1 Novel carboxylic acid derivatives with 5,6 substituted pyrimidine ring, the production and utilization thereof as endothelin receptor antagonists |
| 01/25/2001 | WO2001005770A1 Benzimidazolone derivatives and their use as phosphodiesterase inhibitors |
| 01/25/2001 | WO2001005769A2 Fungicidal heterocyclic aromatic amides and their compositions, methods of use and preparation |
| 01/25/2001 | WO2001005765A1 Cyclic amides and imides having selective antagonist activity at alpha-1d adrenergic receptor |
| 01/25/2001 | WO2001005762A2 Biphenyl derivatives, production thereof and use as mtp inhibitors |
| 01/25/2001 | WO2001005758A2 Indoles and indazoles for the treatment of migraine |
| 01/25/2001 | WO2001005398A1 Phosphate transport inhibitors |
| 01/25/2001 | WO2000071515A3 INHIBITORS OF FACTOR Xa |
| 01/25/2001 | DE19934272A1 New N-phenyl-tetrahydroisoquinoline-sulfonamide derivatives are antiviral agents especially useful for treating cytomegalovirus infections |
| 01/25/2001 | DE19933926A1 Biphenylderivate, ihre Herstellung und ihre Verwendung als Arzneimittel Biphenyl derivatives, their preparation and their use as medicaments |
| 01/25/2001 | DE19933164A1 Neue Carbonsäurederivate mit 5,6 substituiertem Pyrimidinring, ihre Herstellung und Verwendung als Endothelin Rezeptorantagonisten New carboxylic acid derivatives with 5,6-substituted pyrimidine ring, their preparation and use as endothelin receptor antagonists |
| 01/25/2001 | CA2380727A1 Nitrogen containing heterobicycles as factor xa inhibitors |
| 01/25/2001 | CA2379657A1 Phosphate transport inhibitors |
| 01/25/2001 | CA2379554A1 Benzimidazolone derivatives and their use as phosphodiesterase inhibitors |
| 01/25/2001 | CA2379545A1 Novel carboxylic acid derivatives with 5,6 substituted pyrimidine ring, the production and utilization thereof as endothelin receptor antagonists |
| 01/25/2001 | CA2379064A1 Bradykinin b1 receptor antagonists |
| 01/25/2001 | CA2378181A1 Conjugates of sodium channel blockers and methods of using the same |
| 01/25/2001 | CA2378084A1 Novel diphenyl-piperidine derivate |
| 01/25/2001 | CA2378047A1 Heterocyclic compounds for the treatment of migraine |
| 01/25/2001 | CA2377527A1 Heteroaromatic ring compounds |
| 01/24/2001 | EP1070715A1 Arylpiperidine derivatives and use thereof |
| 01/24/2001 | EP1070714A1 Amidine compounds |
| 01/24/2001 | EP1070713A1 Quinolonecarboxylic acid derivatives or salts thereof |
| 01/24/2001 | EP1070712A1 Nitrogen-containing heterocyclic compounds having antiplatelet aggregation effect and medicinal use thereof |
| 01/24/2001 | EP1070711A2 Heteroaryl-substituted pyrrole derivatives, their preparation and their therapeutic uses |
| 01/24/2001 | EP1070710A2 Dithiolan derivatives, their preparation and their therapeutic effect |
| 01/24/2001 | EP1070708A1 Triazole and imidazole derivatives |
| 01/24/2001 | EP1070060A1 Heterocyclic glycyl beta-alanine derivatives as vitronectin antagonists |
| 01/24/2001 | EP1070054A1 Amine compounds, their production and their use as somatostatin receptor antagonists or agonists |
| 01/24/2001 | EP1070050A1 N-aryloxyethyl-indoly-alkylamines for the treatment of depression (5-ht1a receptor active agents) |
| 01/24/2001 | EP1070046A1 Propanolamine derivatives |
| 01/24/2001 | EP0931080A4 Amorphous paroxetine composition |
| 01/24/2001 | EP0837852B1 Pesticidal sulfur compounds |
| 01/24/2001 | EP0706523B1 Substituted arylthioalkylthiopyridines |
| 01/24/2001 | EP0573568B1 Use of nicotinic analogs for treatment of degenerative diseases of the nervous system |
| 01/24/2001 | CN1281439A 4-Hydroxyquinoline-3-carboxamides and hydrazides as antiviral agents |
| 01/24/2001 | CN1281438A Piperazine compounds and medical use thereof |
| 01/24/2001 | CN1281433A Hydroxamic acid derivatives as matrix metalloprotease (MMP) inhibitors |